Imaging, delineation and immobilization: MRI and MR-spectroscopy.- PET imaging in prostate cancer.- Phase contrast X-ray imaging- next generation CT imaging.- Organ contouring for IMRT.- General aspects of patient immobilization.- Internal immobilization: From rectal balloon to hyaluronic acid.- Clinical endpoints: Biochemical recurrence- a valuable endpoint?.- Overall and disease-free survival - too long to wait?.- Late toxicity - current scoring concepts.- Quality of life: Assessment and Correlates.- Dose escalation and new radiation techniques: Dose escalation - an update on randomized clinical trials.- IMRT for prostate cancer.- IGRT- how and when.- Tracking in prostate cancer.- Locally advanced disease: Techniques of pelvic lymphatic irradiation.- Prophylactic treatment of the pelvic lymphatics: pro.- Prophylactic treatment of the pelvic lymphatics: contra.- Hormonal therapy and radiation therapy - randomized and prospective trials.- Treatment of clinically involved lymph nodes.- Hypofractionation: Hypofractionation in prostate cancer- biological aspects.- Hypofractionation: Clinical data.- Simultaneous integrated boost techniques.- Brachytherapy: Principals of 3D, highly conformal brachytherapy.- Seed implantation.- HDR brachytherapy.- Adjuvant treatment and salvage treatment: Target volume definition in postoperative radiotherapy.- Randomized trials for adjuvant radiotherapy.- Salvage radiotherapy after radical prostatectomy.- Salvage prostatectomy after radiotherapy.- Use of protons and heavy ions: Proton therapy for prostate cancer: technological and clinical aspects.- There is evidence for the superiority of protons or heavy ions, pro.- There is evidence for the superiority of protons or heavy ions, contra._